Details for Patent: 6,335,032
✉ Email this page to a colleague
Summary for Patent: 6,335,032
Title: | Orally administrable solid dosage form |
Abstract: | An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed. |
Inventor(s): | Liebowitz; Stephen M. (Neshanic Station, NJ), Stupak; Elliot I. (West Caldwell, NJ), Chaudry; Imtiaz A. (North Caldwell, NJ), Vadino; Winston A. (Whitehouse Station, NJ), Bowen; Frank E. (Rutherford, NJ) |
Assignee: | Schering Corporation (Kenilworth, NJ) |
Application Number: | 09/518,871 |
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 6,335,032
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,335,032
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 008977 | ⤷ Try a Trial | |||
Austria | 234103 | ⤷ Try a Trial | |||
Australia | 1668301 | ⤷ Try a Trial | |||
Australia | 2199199 | ⤷ Try a Trial | |||
Australia | 742943 | ⤷ Try a Trial | |||
Australia | 762826 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |